Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gemcitabine, use different ways to stop tumor
cells from dividing so they stop growing or die. Celecoxib may stop the growth of pancreatic
cancer by stopping blood flow to the tumor and blocking the enzymes necessary for tumor cell
growth. Combining gemcitabine with celecoxib may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving gemcitabine together with celecoxib
works in treating patients with metastatic pancreatic cancer.